Device Using Dielectrophoresis Could Improve Tuberculosis Detection
A diagnostic device using dielectrophoresis holds promise for improving tuberculosis detection and treatment of patients in high-endemic, under-resourced areas.
Read MorePosted by Melanie Hamilton-Basich | Jun 26, 2023 | Molecular Diagnostics, Tuberculosis |
A diagnostic device using dielectrophoresis holds promise for improving tuberculosis detection and treatment of patients in high-endemic, under-resourced areas.
Read MorePosted by Chris Wolski | Jun 15, 2023 | Clinical Chemistry |
The onus is on clinical laboratories to process a high volume of clinical chemistry tests as efficiently and accurately as possible.
Read MorePosted by Melanie Hamilton-Basich | Jun 9, 2023 | Covid 19 |
Scientists used AI to develop a simple one-pot test for both COVID-19 and hepatitis that takes just a few minutes, and hope to improve the technology for other simpler COVID and hepatitis tests.
Read MorePosted by Melanie Hamilton-Basich | Jun 8, 2023 | Covid 19, Sequencing Systems |
Using a CRISPR-based depletion technology and NGS overcomes limitations by targeting and removing abundant host and microbial rRNA sequences, making NGS suitable for pandemic preparedness.
Read MorePosted by Melanie Hamilton-Basich | Jun 7, 2023 | Covid 19, Molecular Diagnostics, POC Reagents & Test Kits |
Cue Health has received De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use.
Read More